• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家兔离体灌注肾血管阻力的产后发育:一氧化氮和血管紧张素II的调节作用

Postnatal development of vascular resistance of the rabbit isolated perfused kidney: modulation by nitric oxide and angiotensin II.

作者信息

Simeoni U, Zhu B, Muller C, Judes C, Massfelder T, Geisert J, Helwig J J

机构信息

Laboratoire de Pharmacologie Physiologie Réno-vasculaire (CJF INSERM 9409), Faculté de Médecine, Université Louis Pasteur, Strasbourg, France.

出版信息

Pediatr Res. 1997 Oct;42(4):550-5. doi: 10.1203/00006450-199710000-00022.

DOI:10.1203/00006450-199710000-00022
PMID:9380452
Abstract

Studies were performed on isolated perfused kidneys (IPK) from postnatal developing rabbits to ask 1) whether the high renal vascular resistance (RVR) at birth involves intrinsic renal mechanisms, 2) whether nitric oxide (NO) release is involved in the modulation of renal vascular tone, and 3) whether NO modulates exogenous angiotensin II (AII)-induced vasoconstrictions. Kidneys isolated from 1-wk-old (during nephrogenesis), 3-wk-old (after nephrogenesis), and 6-wk-old rabbits were perfused in the presence of 10(-5) M indomethacin. RVR decreased with age from 12.7 +/- 0.6 at 1 wk to 10.1 +/- 0.5 mm Hg min g mL-1 at 6 wk. N omega-Nitro-L-arginine methyl ester (L-NAME, 10(-4) M) comparably increased RVR by about 30% at 1, 3, and 6 wk. The vasoconstrictions induced by 10(-8) M AII increased basal pressure from 28% at 1 wk to 78% at 6 wk and were potentiated by L-NAME by about 100%. In contrast, the vasoconstrictions induced by 10(-10) M AII decreased from 8% at 1 wk to 0% at 6 wk and were potentiated by L-NAME by about 250% at 1 and 3 wk. We conclude that during postnatal development: 1) RVR in IPK decreases in absence of AII and extrarenal influences, suggesting that high RVR at birth involves intrinsic mechanisms, 2) L-Arg/NO modulates basal tonus in developing IPK, and, 3) renal vasoconstrictor responses to exogenous AII are buffered by NO at early postnatal stages and follow an AII concentration-dependent developmental pattern. A specific neonatal high affinity AII/NO interaction disappearing after nephrogenesis completion precedes a low affinity AII/NO interaction, which progressively increases toward adult ages. These findings are in favor of a specific involvement of AII-NO interactions in the control of developing renal hemodynamics.

摘要

对出生后发育中的家兔的离体灌注肾(IPK)进行了研究,以探讨:1)出生时高肾血管阻力(RVR)是否涉及肾脏内在机制;2)一氧化氮(NO)释放是否参与肾血管张力的调节;3)NO是否调节外源性血管紧张素II(AII)诱导的血管收缩。从1周龄(肾发生期)、3周龄(肾发生后)和6周龄家兔分离的肾脏在10(-5) M吲哚美辛存在下进行灌注。RVR随年龄从1周时的12.7±0.6降至6周时的10.1±0.5 mmHg min g mL-1。Nω-硝基-L-精氨酸甲酯(L-NAME,10(-4) M)在1、3和6周时使RVR同等程度增加约30%。10(-8) M AII诱导的血管收缩使基础压力从1周时的28%增加到6周时的78%,并被L-NAME增强约100%。相反,10(-10) M AII诱导的血管收缩从1周时的8%降至6周时的0%,并在1和3周时被L-NAME增强约250%。我们得出结论,在出生后发育过程中:1)在没有AII和肾外影响的情况下,IPK中的RVR降低,表明出生时的高RVR涉及内在机制;2)L-精氨酸/NO调节发育中IPK的基础张力;3)在出生后早期阶段,肾脏对外源性AII的血管收缩反应受到NO的缓冲,并遵循AII浓度依赖性发育模式。肾发生完成后消失的特定新生儿高亲和力AII/NO相互作用先于低亲和力AII/NO相互作用,后者随着年龄增长逐渐增加。这些发现支持AII-NO相互作用在发育中的肾脏血流动力学控制中具有特定作用。

相似文献

1
Postnatal development of vascular resistance of the rabbit isolated perfused kidney: modulation by nitric oxide and angiotensin II.家兔离体灌注肾血管阻力的产后发育:一氧化氮和血管紧张素II的调节作用
Pediatr Res. 1997 Oct;42(4):550-5. doi: 10.1203/00006450-199710000-00022.
2
AT2-antagonist sensitive potentiation of angiotensin II-induced vasoconstrictions by blockade of nitric oxide synthesis in rat renal vasculature.通过阻断大鼠肾血管中的一氧化氮合成,AT2拮抗剂对血管紧张素II诱导的血管收缩有敏感性增强作用。
Br J Pharmacol. 1997 Dec;122(7):1495-501. doi: 10.1038/sj.bjp.0701505.
3
Demonstration of the existence of nitric oxide-independent as well as nitric oxide-dependent vasodilator mechanisms in the in situ renal circulation in near term pregnant rats.在近足月妊娠大鼠的原位肾循环中一氧化氮非依赖性以及一氧化氮依赖性血管舒张机制存在的证明。
Br J Pharmacol. 1997 Sep;122(2):307-15. doi: 10.1038/sj.bjp.0701363.
4
Effects of prostaglandins and nitric oxide on the renal effects of angiotensin II in the anaesthetized rat.前列腺素和一氧化氮对麻醉大鼠体内血管紧张素II肾脏效应的影响。
Br J Pharmacol. 1998 Aug;124(7):1467-74. doi: 10.1038/sj.bjp.0702003.
5
NO-independent mechanism mediates tempol-induced renal vasodilation in SHR.在自发性高血压大鼠中,不依赖一氧化氮的机制介导了tempol诱导的肾血管舒张。
Am J Physiol Renal Physiol. 2005 Dec;289(6):F1227-34. doi: 10.1152/ajprenal.00116.2005. Epub 2005 Jul 20.
6
AT2 antagonist-sensitive potentiation of angiotensin II-induced constriction by NO blockade and its dependence on endothelium and P450 eicosanoids in rat renal vasculature.在大鼠肾血管系统中,通过一氧化氮(NO)阻断实现血管紧张素II诱导的收缩的AT2拮抗剂敏感性增强及其对内皮和细胞色素P450类花生酸的依赖性。
Br J Pharmacol. 1998 Jul;124(5):946-52. doi: 10.1038/sj.bjp.0701906.
7
Modulation of renal vasoconstrictor effect of NG-nitro-L-arginine in rabbit by angiotensin II and alpha-1 adrenergic receptor blockade.血管紧张素II和α-1肾上腺素能受体阻断对兔NG-硝基-L-精氨酸肾血管收缩作用的调节
J Pharmacol Exp Ther. 1994 Sep;270(3):1152-7.
8
[Role of nitric oxide in the modulation of the vascular response to angiotensin II in hypertensive rats].[一氧化氮在高血压大鼠血管对血管紧张素II反应调节中的作用]
Arch Inst Cardiol Mex. 1996 Jul-Aug;66(4):306-12.
9
Blood pressure (BP) and renal vasoconstrictor responses to acute blockade of nitric oxide: persistence of renal vasoconstriction despite normalization of BP with either verapamil or sodium nitroprusside.
J Pharmacol Exp Ther. 1995 Sep;274(3):1135-41.
10
Endothelium-derived nitric oxide modulates renal hemodynamics in the developing piglet.内皮衍生的一氧化氮调节发育中小猪的肾血流动力学。
Pediatr Res. 1993 Dec;34(6):750-4. doi: 10.1203/00006450-199312000-00010.

引用本文的文献

1
Angiotensin receptors modulate the renal hemodynamic effects of nitric oxide in conscious newborn lambs.血管紧张素受体调节清醒新生羔羊体内一氧化氮的肾血流动力学效应。
Physiol Rep. 2014 May 28;2(5). doi: 10.14814/phy2.12027. Print 2014 May 1.
2
Nitric oxide synthesis in the adult and developing kidney.成人及发育中肾脏中的一氧化氮合成
Electrolyte Blood Press. 2006 Mar;4(1):1-7. doi: 10.5049/EBP.2006.4.1.1.